Cargando…
Lubiprostone for the Treatment of Clozapine-Induced Constipation: A Case Series
Clozapine-induced constipation is an increasingly recognized adverse reaction that frequently impairs optimal management of treatment-resistant schizophrenia. The Food and Drug Administration recently strengthened an existing warning for clozapine, citing constipation as an adverse effect that can p...
Autores principales: | Torrico, Tyler J, Kaur, Snehpreet, Dayal, Manik, Eagala, Pooja, Weinstein, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249388/ https://www.ncbi.nlm.nih.gov/pubmed/35785010 http://dx.doi.org/10.7759/cureus.25576 |
Ejemplares similares
-
Clozapine-Induced Pneumonitis: A Case Report
por: Torrico, Tyler, et al.
Publicado: (2020) -
Lubiprostone: a novel treatment for chronic constipation
por: Lacy, Brian E, et al.
Publicado: (2008) -
Clozapine-Induced Constipation: A Case Report and Review of Current Management Guidelines
por: Patel, Rikinkumar S, et al.
Publicado: (2021) -
The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation
por: Pennington, Becky, et al.
Publicado: (2018) -
A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly
por: Gras-Miralles, Beatriz, et al.
Publicado: (2013)